SCHEMBL31043936

SCHEMBL31043936

Cc1cc(C(=O)NCc2ccc(NC(=O)OCc3ccc(Cl)cc3)cc2)n(C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ KMT2A Q03164 4/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ GALR3 O60755 1/20 0.47
▸ NR2F2 P24468 1/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ FLT1 P17948 1/20 0.46
▸ KDR P35968 1/20 0.46
▸ CYP1A2 P05177 3/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ DHODH Q02127 1/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ SCD O00767 1/20 0.44
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31043874 0.88 L3MBTL1 (0.44) MAPTL3MBTL1KMT2ASMN1; SMN2RAB9A
SCHEMBL31043987 0.88 L3MBTL1 (0.44) MAPTNPSR1L3MBTL1KMT2ASMN1; SMN2
SCHEMBL31044019 0.87 SMN1; SMN2 (0.43) MAPTNPSR1L3MBTL1KMT2ASMN1; SMN2
SCHEMBL31029157 0.85 MAPT (0.48) MAPTNPSR1KMT2ASMN1; SMN2MEN1
SCHEMBL31043684 0.85 MAPT (0.48) MAPTNPSR1KMT2ASMN1; SMN2MEN1
SCHEMBL31043762 0.84 RAB9A (0.60) MAPTNPSR1L3MBTL1KMT2ASMN1; SMN2
SCHEMBL31043769 0.82 KMT2A (0.61) MAPTNPSR1L3MBTL1KMT2ASMN1; SMN2
SCHEMBL31043782 0.80 SMN1; SMN2 (0.59) MAPTL3MBTL1KMT2ASMN1; SMN2RAB9A
SCHEMBL31043650 0.80 SMN1; SMN2 (0.59) MAPTNPSR1L3MBTL1KMT2ASMN1; SMN2
SCHEMBL31043578 0.80 NPC1 (0.45) MAPTNPSR1KMT2ASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240279215-A1 NAMPT MODULATORS CYTOKINETICS, INCORPORATED 2024-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240279215-A1 NAMPT MODULATORS NAMPT, SIRT1, NNT MAPT 766/4885NPSR1 795/4885L3MBTL1 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback